Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- DDD +13.6%, BNED +13.2%, HIIQ +10.3%, QEP +10.2%, TWNK +8.3%, HABT +7.5%,ECR +6.8%, ILG +6.1%, GDP +6%, BLDR +5.4%, ITRI +5%, BBY +4.8%, BUD +4.5%,CVEO +4.2%, MYL +3.3%, MMSI +3.3%, UHS +3.3%, CRM +3.2%, AMC +3%, BID +2.9%,HGV +2.5%, RTIX +2.4%, KSS +1.3%, OCLR +1.1%, AXGN +1%, ABEV +0.6%
M&A news:
- AFSI +12.4% (to be acquired by Evergreen Parent for $13.50/share in cash)
- FLY +5.9% (to acquire major aircraft portfolio AirAsia Berhad)
Other news:
- NVAX +24% (announces 'positive' top-line results from its Phase 1/2 clinical trial in older adults of its NanoFlu recombinant influenza vaccine compared to the leading licensed egg-based, high-dose influenza vaccine for older adults)
- NWL +6.3% (Acitivist investor Carl Icahn is said to have recently built a stake in Newell, according to the NY Post)
- FGEN +1% (FDA has granted Fast Track designation for the company's anti-CTGF antibody, pamrevlumab, for the treatment of patients with locally advanced unresectable pancreatic cancer)
Analyst comments:
- CRZO +3% (upgraded to Buy from Hold at Jefferies)
- TWLO +1.4% (initiated with a Buy at BofA/Merrill)